免責事項: 本サイトは、FDA、ClinicalTrials.gov、PubMed、SEC EDGAR などの公式公開データを一般参考用に集約するものであり、医学的助言、診断、治療推奨、投資助言を構成しません。

臨床試験

Virtual Reality Exposure Therapy for Emotion Regulation Difficulties in Adolescent Inpatients

NCT: NCT07709468 · ENROLLING_BY_INVITATION

NCT識別子NCT07709468
ステータスENROLLING_BY_INVITATION
開始日2026-09-15
SponsorPsychiatric University Hospital, Zurich (OTHER)
First posted
Last updated

概要

The goal of this clinical trial is to evaluate whether a therapist-guided virtual reality (VR)-based intervention can improve emotion regulation in adolescents receiving inpatient psychiatric treatment. The study will also assess the feasibility, acceptability, and safety of the intervention, as well as explore factors that may predict treatment response. The main questions it aims to answer are: Does the VR-based intervention improve emotion regulation compared with a VR relaxation control intervention? Does the intervention reduce sensory sensitivities, anxiety, and related psychological symptoms? Which behavioral, physiological, and speech-based measures are associated with treatment response? Researchers will compare a personalized VR exposure intervention with a VR relaxation control intervention. Both groups will receive treatment as usual during their inpatient stay. Participants will: Be randomly assigned to either the VR exposure or the VR relaxation group. Complete questionnaires, behavioral tasks, and clinical assessments before and after the intervention, with a follow-up assessment approximately three months later. Participate in weekly therapist-guided VR sessions throughout their inpatient treatment. Complete additional assessments including speech recordings and standardized behavioral tasks to investigate predictors and mechanisms of treatment response. Throughout the study, participants will be monitored for adverse events and tolerability of the VR intervention.

公式ソース

ClinicalTrials.govで見る →

データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。

↑